¿Hipertensión arterial maligna con microangiopatía trombótica o nefroangioesclerosis maligna mediada por complemento, evento transitorio o permanente? A propósito de un caso

¿Hipertensión arterial maligna con microangiopatía trombótica o nefroangioesclerosis maligna mediada por complemento, evento transitorio o permanente? A propósito de un caso

Resumen: La hipertensión arterial maligna puede presentarse en forma de insuficiencia renal aguda grave, raramente acompañada de microangiopatía trombótica renal. Siendo difícil diferenciarla de otros procesos similares como el síndrome hemolítico urémico atípico, cuyo tratamiento difiere sustancial...

Full description

Bibliographic Details
Main Authors:	José de la Flor, Ana Gomez-Berrocal, Marina Alonso
Format:	Article
Language:	English
Published:	Elsevier España 2022-01-01
Series:	Medicina Clínica Práctica
Subjects:	Malignant arterial hypertension Thrombotic microangiopathy Atypical hemolytic uremic syndrome
Online Access:	http://www.sciencedirect.com/science/article/pii/S2603924921000902

Similar Items

Síndrome nefrótico como manifestación de microangiopatía trombótica secundaria al uso crónico de sunitinib
by: John Fredy Nieto-Ríos, et al.
Published: (2022-11-01)

Microangiopatía trombótica en una paciente con infección por el virus de la inmunodeficiencia humana
by: Ángel Pellicer Cabo, et al.

Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation
by: Mina Lazem, et al.
Published: (2021-05-01)

Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
by: Anja Gäckler, et al.
Published: (2021-01-01)

Hemolysis, Elevated Liver Enzymes, Low Platelets Syndrome Superimposed on Hemolytic Uremic Syndrome
by: Inês Martins, et al.
Published: (2017-04-01)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
by: Eleni Gavriilaki, et al.
Published: (2019-02-01)

Thrombotic microangiopathies: An illustrated review
by: Mouhamed Yazan Abou‐Ismail, et al.
Published: (2022-03-01)

Characteristics and management of thrombotic microangiopathy in kidney transplantation
by: Wonyong Cho, et al.
Published: (2023-03-01)

Efficacy of cascade plasmapheresis in comparison with conventional therapeutic plasma exchange for relapsed atypical hemolytic uremic syndrome: A case report
by: Ashwinkumar Vaidya, et al.
Published: (2022-01-01)

Hemolytic-uremic syndrome: 24 years’ experience of a pediatric nephrology unit
by: Ana Sofia Vilardouro, et al.
Published: (2022-04-01)

A novel atypical hemolytic uremic ayndrome – associated CFH gene in a renal transplant recipient complicating ileum perforation
by: Chih-Yu Shen, et al.
Published: (2022-01-01)

Atypical hemolytic uremic syndrome: a case report
by: B. M. D. B. Basnayake, et al.
Published: (2020-01-01)

Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review
by: Adriana Mocanu, et al.
Published: (2023-03-01)

Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study
by: Nicolas Henry, et al.
Published: (2021-02-01)

Hipertensión maligna
by: Andrés Valdivieso Dávila
Published: (2017-01-01)

Genetic atypical hemolytic uremic syndrome in children: a 20-year experience from a tertiary center
by: Cristiana Maximiano, et al.
Published: (2021-05-01)

A Life-Threating Postpartum Atypical Hemolytic-Uremic Syndrome with Multiorgan Involvement
by: Laura Sarno, et al.
Published: (2022-11-01)

Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes
by: Renaud Prével, et al.
Published: (2022-02-01)

Histopathological features of thrombotic microangiopathies in renal biopsies
by: Miguel Ernandes Neto, et al.
Published: (2019-07-01)

Clinico-Histological Features of Thrombotic Microangiopathy in Renal Biopsies: A Retrospective Study
by: Niraimathi MANICKAM, et al.
Published: (2022-01-01)

Mitomycin C-Induced Renal Insufficiency: A Case Report
by: Mei-Chin Wen, et al.
Published: (2003-06-01)

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
by: Tommaso Mazzierli, et al.
Published: (2023-01-01)

Presumptive thrombotic thrombocytopenic purpura following a hump-nosed viper (Hypnale hypnale) bite: a case report
by: Milinda Withana, et al.
Published: (2014-08-01)

The manifestation’s feature of atypical hemolytic uremic syndrome using eculizumab (clinical case)
by: N.N. Guranova, et al.
Published: (2021-09-01)

Diclofenac-induced thrombotic thrombocytopenic purpura with concomitant complement dysregulation: a case report and review of the literature
by: Jose Perez Lara, et al.
Published: (2019-06-01)

Red blood cell-derived arginase release in hemolytic uremic syndrome
by: Niklas Friberg, et al.
Published: (2024-01-01)

Anuria, Sudden Blindless, Confusion: A Case of Unusual 'Adult Still Disease'
by: YUE Cai, et al.
Published: (2022-01-01)

A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome
by: Saeed AlZabali, et al.
Published: (2022-11-01)

Thrombotic Microangiophatic in the ICU, postpartum hemolytic uremic syndrome: case report
by: Zulma Urbina, et al.
Published: (2016-07-01)

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study
by: Jan Menne, et al.
Published: (2019-04-01)

Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series
by: Tristan de Nattes, et al.
Published: (2020-01-01)

Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
by: Sara Madureira Gomes, et al.
Published: (2021-04-01)

The use of eculizumab in gemcitabine induced thrombotic microangiopathy
by: Vinod Krishnappa, et al.
Published: (2018-01-01)

A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
by: Vanessa Vilani Addad, et al.
Published: (2023-11-01)

Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia
by: Emine Hidayet, et al.
Published: (2022-06-01)

Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review
by: Marija Malgaj Vrečko, et al.
Published: (2022-09-01)

The utility of platelet activation biomarkers in thrombotic microangiopathies
by: Mohammad Al-Tamimi, et al.
Published: (2022-05-01)

Clinical case of thrombotic microangiopathy in obstetric practice
by: M. N. Mochalova, et al.
Published: (2017-06-01)

Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies—what intensivists need to know
by: Jean-Louis Vincent, et al.
Published: (2018-06-01)

The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report
by: Eun-Ki Min, et al.
Published: (2023-03-01)